公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Functional role of soluble receptor for advanced glycation end products in stroke | SUNG-CHUN TANG ; Wang Y.-C.; Li Y.-I.; Lin H.-C.; Manzanero S.; Hsieh Y.-H.; Phipps S.; Hu C.-J.; Chiou H.-Y.; Huang Y.-S.; WEI-SHIUNG YANG ; Mattson M.P.; Arumugam T.V.; JIANN-SHING JENG | 72 | 70 | ||
2019 | Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutation | Cheng Y.-F.; Chan Y.-H.; Hu C.-J.; Lu Y.-C.; Saeki T.; Hosoya M.; Saegusa C.; Fujioka M.; Okano H.; Weng S.-M.; Hsu C.-J.; Chang K.-H.; Chen-Chi Wu | Stem Cell Research | 5 | 4 | |
2020 | HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression | Fang Y.-C.; Chan L.; Liou J.-P.; YONG-KWANG TU ; Lai M.-J.; Chen C.-I.; Vidyanti A.N.; Lee H.-Y.; Hu C.-J. | Journal of Cellular and Molecular Medicine | 12 | 8 | |
2011 | High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease | TSUNG-YANG WANG ; Hu C.-J.; Kuo C.-W.; Chen Y.; Lin J.-L.; Yang C.-W.; Yen T.-H. | Nephrology | 16 | 15 | |
2016 | Homozygous ALDH2*2 is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men | Sung Y.-F.; Lu C.-C.; Lee J.-T.; Hung Y.-J.; Hu C.-J.; JIANN-SHING JENG ; Chiou H.-Y.; Peng G.-S. | Stroke | 29 | 26 | |
2020 | Imaging-based pregenetic screening for NOTCH3 p.R544C mutation in ischemic stroke in Taiwan | Cheng Y.-W.; CHIH-HAO CHEN ; Hu C.-J.; Chiou H.-Y.; SUNG-CHUN TANG ; JIANN-SHING JENG | Annals of Clinical and Translational Neurology | 5 | 6 | |
2015 | Impact of diabetes on stroke risk and outcomes: Two nationwide retrospective cohort studies | Liao C.-C.; Shih C.-C.; Yeh C.-C.; YI-CHENG CHANG ; Hu C.-J.; Lin J.-G.; Chen T.-L. | Medicine (United States) | 40 | 41 | |
2017 | Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studies | Chu L.-M.; Liu C.-C.; Yeh C.-C.; YI-CHENG CHANG ; Hu C.-J.; Shih C.-C.; Cherng Y.-G.; Chen T.-L.; Liao C.-C. | Atherosclerosis | 5 | 4 | |
2021 | Interactive Effects of a Combination of the HDAC3 and HDAC9 Genes with Diabetes Mellitus on the Risk of Ischemic Stroke | Chiou H.-Y.; Bai C.-H.; Lien L.-M.; Hu C.-J.; JIANN-SHING JENG ; SUNG-CHUN TANG ; Lin H.-J.; Hsieh Y.-C. | Thrombosis and Haemostasis | 3 | 3 | |
2021 | Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction | Liu H.-C.; Chen H.-H.; Ho C.-S.; Chang J.-F.; Lin C.-C.; MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Yang S.-Y. | Neurology and Therapy | 0 | 0 | |
2020 | Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study | MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Liu B.-H.; Chang Y.-T.; Yang C.-C.; Yang S.-Y. | Nanomedicine: Nanotechnology, Biology, and Medicine | 21 | 19 | |
2019 | One-Year Risk of Recurrent Stroke and Death Associated with Vertebrobasilar Artery Stenosis and Occlusion in a Cohort of 10,515 Patients | Qureshi A.I.; Qureshi M.H.; Lien L.-M.; Lee J.-T.; JIANN-SHING JENG ; Hu C.-J.; Lai T.-C.; Liu C.-H.; Chen C.-H.; Chen P.-L.; Chen T.-S.; Li J.-Y.; Lin C.-L.; Hsu C.Y. | Cerebrovascular Diseases | 12 | 10 | |
2013 | Onset headache predicts good outcome in patients with first-ever ischemic stroke | Chen P.-K.; Chiu P.-Y.; Tsai I.-J.; Tseng H.-P.; Chen J.-R.; SHIN-JOE YEH ; Sheu J.-J.; Chung C.-P.; Wu M.-H.; Hu C.-J.; Chang C.-Y.; Wei C.-Y.; Yip P.-K.; Sung S.-F.; Wang S.-J.; Hsu C.Y. | Stroke | 32 | 28 | |
2021 | Pathological circulating factors in moyamoya disease | Fang Y.-C.; Wei L.-F.; Hu C.-J.; YONG-KWANG TU | International Journal of Molecular Sciences | 17 | 14 | |
2019 | Persistence and adherence to rivastigmine in patients with dementia: Results from a noninterventional, retrospective study using the National Health Insurance research database of Taiwan | Chang C.-J.; Chou T.-C.; Chang C.-C.; TA-FU CHEN ; Hu C.-J.; Fuh J.-L.; Wang W.; Chen C.-M.; Hsu W.; Huang C.-C. | Alzheimer's and Dementia: Translational Research and Clinical Interventions | 6 | 4 | |
2019 | Prevalence and clinical characteristics of stroke patients with p.R544C NOTCH3 mutation in Taiwan | SUNG-CHUN TANG ; Chen Y.-R.; Chi N.-F.; CHIH-HAO CHEN ; Cheng Y.-W.; Hsieh F.-I.; Hsieh Y.-C.; Yeh H.-L.; Sung P.-S.; Hu C.-J.; Chern C.-M.; Lin H.-J.; Lien L.-M.; Peng G.-S.; Chiou H.-Y.; JIANN-SHING JENG | Annals of Clinical and Translational Neurology | 23 | 21 | |
2021 | Prognostic impact of renal dysfunction on embolic stroke of undetermined source—Role beyond CHA2DS2-VASc score: Results from Taiwan Stroke Registry | Chua S.-K.; Hsieh F.-I.; Hu C.-J.; Wang I.-K.; Lee J.-T.; Yeh H.-L.; Lin K.-Y.; Lai T.-C.; Sun Y.; JIANN-SHING JENG ; Lin C.-L.; Lien L.-M.; Hsu C.Y.; Taiwan Stroke Registry Investigators | European Journal of Neurology | 2 | 1 | |
2020 | Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment | Kaur N.; Fang Y.-C.; Lee H.-Y.; Singh A.; Nepali K.; Lin M.-H.; Yeh T.-K.; Lai M.-J.; Chan L.; YONG-KWANG TU ; Banerjee S.; Hu C.-J.; Liou J.-P. | European Journal of Medicinal Chemistry | 12 | 10 | |
2004 | Relationship between vertebral bone marrow blood perfusion and common carotid intima-media thickness in aging adults | Chen W.-T.; TIFFANY TING-FANG SHIH ; Hu C.-J.; Chen R.-C.; Tu H.-Y. | Journal of Magnetic Resonance Imaging | 12 | 10 | |
2018 | Renal dysfunction increases the risk of recurrent stroke in patients with acute ischemic stroke | Wang I.-K.; Lien L.-M.; Lee J.-T.; Liu C.-H.; Chen C.-H.; Lin C.-H.; JIANN-SHING JENG ; Hu C.-J.; Yen T.-H.; Chen S.-T.; Chiu H.-C.; Tsai I.-J.; Sung F.-C.; Hsu C.Y.; Taiwan Stroke Registry Investigators | Atherosclerosis | 19 | 19 |